These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 3707155
1. [A phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with head and neck cancer]. Takeda C. Gan To Kagaku Ryoho; 1986 May; 13(5):1970-9. PubMed ID: 3707155 [Abstract] [Full Text] [Related]
2. [A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group]. Kimura K. Gan To Kagaku Ryoho; 1986 Feb; 13(2):368-75. PubMed ID: 3947112 [Abstract] [Full Text] [Related]
3. [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study]. Saito T, Kasai Y, Wakui A, Furue H, Majima H, Nitani H, Niijima T, Takeda C, Abe O, Koyama Y. Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1060-9. PubMed ID: 3963850 [Abstract] [Full Text] [Related]
4. [Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group]. Niijima T, Koyanagi T, Sakashita S, Origasa S, Akaza H, Machida T, Koiso K, Rinsho K, Aso Y, Suzuki K. Gan To Kagaku Ryoho; 1986 Feb; 13(2):224-31. PubMed ID: 3947104 [Abstract] [Full Text] [Related]
5. [Phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in gastrointestinal cancer]. Takenaka K, Tamada R, Hiramoto Y, Inokuchi K, Saku M, Oka N, Kano T, Noda S, Nagasaki S, Toda T. Gan To Kagaku Ryoho; 1985 Nov; 12(11):2155-60. PubMed ID: 4062315 [Abstract] [Full Text] [Related]
9. [Phase II study of (2" R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with advanced or recurrent gastric cancer. Clinical study group of THP for gastric cancer in Japan]. Nakao I, Wakui A, Hattori T, Sugimachi K, Saito T. Gan To Kagaku Ryoho; 1991 Jul; 18(8):1325-32. PubMed ID: 2069402 [Abstract] [Full Text] [Related]
11. [Multi-institutional cooperative study on combination chemotherapy with THP, CDDP and 5-FU for squamous cell carcinoma of the head and neck]. Urade M, Yanagisawa T, Kishimoto H, Yoshioka W, Teranobu O, Shigeta Y, Komori T, Shimada K, Ohnishi M, Tanaka Y, Kamiya Y, Akazawa N, Oko T, Takahashi N, Adachi R, Tanigaki S, Hirata Y, Yakushiji N, Kitamura R, Hashikawa N, Hyogo Oncology Group for Oromaxillary Tumors. Gan To Kagaku Ryoho; 2001 Jun; 28(6):789-95. PubMed ID: 11432346 [Abstract] [Full Text] [Related]
14. [Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)]. Nakada H, Ogawa M, Miyamoto H, Inagaki J, Horikoshi N, Inoue K, Ikeda K, Usui N, Adachi K, Okada Y. Gan To Kagaku Ryoho; 1984 Jan; 11(1):138-42. PubMed ID: 6696455 [Abstract] [Full Text] [Related]
15. [Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)]. Inuyama Y, Kida A, Tsukuda M, Kohno N, Satake B. Gan To Kagaku Ryoho; 1998 Jul; 25(8):1151-8. PubMed ID: 9679577 [Abstract] [Full Text] [Related]
16. [Intravesical chemotherapy of (2''R)-4'-O-tetrahydropyranyladriamycin in bladder tumor]. Masuda H, Hirose J, Suzuki K, Tajima A, Aso Y. Gan To Kagaku Ryoho; 1986 Jul; 13(7):2411-4. PubMed ID: 3729494 [Abstract] [Full Text] [Related]